Blume Jensen Peter Insider Trades

Insider Trading History

Track insider trading activity for Blume Jensen Peter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.5M 2,259,046 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 180,095 shares
$1.65
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $599k 386,343 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 72,706 shares
$1.65
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $486k 313,637 shares
Last Trade
May 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$941 490 shares
$1.92
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.22M 2,078,951 shares
Last Trade
May 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.41k 1,253 shares
$1.92
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $288k 185,495 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$280k 185,495 shares
$1.51
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $647k 417,210 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 417,210 shares
$1.51
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.22M 2,080,204 shares
Last Trade
Feb 21, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.8k 14,265 shares
$1.53
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $487k 314,127 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$944 579 shares
$1.63
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.25M 2,094,469 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.12k 1,302 shares
$1.63
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.25M 2,095,771 shares
Last Trade
Jan 14, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.3k 49,000 shares
$1.68
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.17M 2,046,771 shares
Last Trade
Nov 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.8k 19,904 shares
$2.30
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.2M 2,066,675 shares
Last Trade
Nov 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$134k 59,765 shares
$2.24
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $488k 314,706 shares
Last Trade
Nov 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.1k 490 shares
$2.24
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.3M 2,126,440 shares
Last Trade
Aug 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.3k 19,905 shares
$1.32
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.33M 2,146,345 shares
Last Trade
Aug 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$83.8k 60,256 shares
$1.39
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.42M 2,206,111 shares
Last Trade
May 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.9k 19,904 shares
$1.15
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.45M 2,226,015 shares
Last Trade
May 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$68.7k 60,257 shares
$1.14
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $605k 390,390 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.82M 530,930 shares
$5.31
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.54M 2,285,781 shares
Last Trade
Feb 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 19,904 shares
$5.54
$1.55
Acrivon Therapeutics
Acrivon Therapeutics ACRV
President And CEO
Holding Value $3.57M 2,305,685 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$205k 37,731 shares
$5.42
$1.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up